The Imperative for KAM in Pharma
PM360
OCTOBER 28, 2022
This capability requires an orchestrated, cross-functional go-to-market model designed to address the needs and engagement preferences of a defined segment of large, complex, and strategically important healthcare systems and groups. How should leading pharma companies respond? ZS surveyed administrators from major U.S.
Let's personalize your content